IONS vs PRPL · rev $226.6M vs rev $487.9M
Ionis Pharmaceuticals Inc (IONS) versus Purple Innovation Inc (PRPL) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Purple Innovation Inc (PRPL) is a furnishings, fixtures & appliances company listed on NASDAQ.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
Latest reported PRPL revenue for 2024-12-31 was $487.9M. Net income was -$98.1M. Revenue was down 4.4% from 2023-12-31 to 2024-12-31. PRPL currently screens at market cap $44.9M.
IONS currently screens at market cap $12.28B. PRPL currently screens at market cap $44.9M.
Not investment advice. Open the IONS and PRPL stock pages for the full models.
Not investment advice.